Caplacizumab

Red

Brand Name(s):Cablivi

Indication:Thrombotic thrombocytopenic purpura (acquired) in conjunction with plasma exchange and immunosuppression.

Rationale:1,2

Considered:Jun-19

Review Date:Jul-24

Comments: